Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study developed and initially validated the Scale of Alopecia Areata Distress (SAAD), a 41-item tool designed to measure psychosocial distress among US adults with alopecia areata.

This study found that androgenetic alopecia negatively impacts the emotional and social well-being of Polish men, particularly younger individuals, with 66.7% reporting a significant effect on self-esteem.

This review analyzes quality of life instruments for pediatric alopecia areata and reports inconsistencies in their coverage, suggesting the need for new tools to comprehensively assess all affected life aspects.

This study found that androgenetic alopecia significantly impairs quality of life among Nigerian patients, especially in areas like emotions, stigmatization, and self-confidence, highlighting the importance of psychosocial support.

In this study, dandruff treatment with anti-dandruff shampoos was found to effectively reduce symptoms and enhance emotional wellbeing, indirectly improving daily functioning by alleviating scalp-related emotional distress, though it did not affect self-esteem.

Alopecia areata significantly affects emotional well-being and quality of life, especially in younger adults.

This study found that patients with androgenetic alopecia reported more impact on their quality of life in terms of emotions, functioning, and symptoms than those with alopecia areata.

This study reported that an Ayurveda-based regimen of Guduchi, Ashwagandha, and Curcumin may safely improve quality of life, including physical and emotional functioning, in breast cancer patients receiving conventional therapy, with no serious adverse events over an 8-week period.

This study observed that alopecia areata patients experience significant psychosocial issues, with a high prevalence of anxiety, depression, and impaired quality of life across symptoms, functioning, and emotions.

This study found that younger male patients with androgenic alopecia experienced greater stigmatization and emotional instability but maintained higher self-assuredness and better overall quality of life compared to older patients.

This study found that Romanian men with schizophrenia had better mental functioning than women, and atypical antipsychotics were associated with improved quality of life across various dimensions for all patients.

This study found that platelet-rich plasma treatment significantly improved patients' quality of life and emotional well-being 3-5 months after treatment for hair loss.

In this study, researchers found that female pattern hair loss significantly reduces quality of life, particularly affecting younger women who experience more stigmatization, poorer emotional stability, and higher dermatology life quality index scores compared to older women.

This study found that Slovak breast cancer survivors experience moderate overall quality of life, with variations across domains linked to treatment types and sociodemographic factors, pointing to the need for tailored supportive care.

Alopecia areata and androgenetic alopecia affect quality of life similarly.

Asian women experiencing hair loss often feel embarrassed and unhappy, but hair transplantation can offer natural-looking results and improve their self-confidence.

This study found that sacituzumab govitecan improved health-related quality of life in most areas for patients with HR+/HER2− metastatic breast cancer compared to chemotherapy, except for increased diarrhea, supporting its use as a treatment option.

This study found that alopecia areata severity significantly influences the health-related quality of life impacts and treatment patterns among affected individuals.

This review highlights the significant impact of alopecia on personal identity and social interactions, emphasizing the need for personalized, non-pharmacological interventions and improved collaboration in healthcare training to better support those with appearance-altering conditions.

This review covers cross-sex hormone therapy for gender dysphoria, noting improvements in psychological symptoms and quality of life but lacking definitive long-term safety data.

This study found that the quality of life for Japanese lupus erythematosus patients with skin manifestations improved after treatment, though female gender and older age were associated with poorer outcomes in certain quality of life domains.

This study reported that over 70% of adults with primary cicatricial alopecia experienced impaired quality of life, primarily influenced by trichodynia and anxiety.

This study found that an 8-week practice of pranic meditation was associated with improved quality of life and mental health scores in breast cancer survivors, though further research is needed for confirmation.

This study found that adding concurrent and adjuvant temozolomide to radiotherapy for patients with anaplastic gliomas improved progression-free survival without adversely affecting health-related quality of life.

This study found that the epirubicin-docetaxel chemotherapy regimen for metastatic breast cancer resulted in a clinical response in 55% of patients, with maintained global quality of life despite some impairments.

This study found that an Ayurveda-based regimen including Guduchi, Ashwagandha, and Curcumin may improve quality of life and safely reduce symptoms in breast cancer patients undergoing conventional therapy.

This study suggests that an Ayurveda-based regimen including Guduchi, Ashwagandha, and Curcumin may enhance quality of life and is safe for breast cancer patients receiving conventional therapy.

This article reviews the psychological, social, and biological impacts of polycystic ovary syndrome on women of reproductive age and reports no new experimental results.

This study concluded that heredity is associated with hair loss, while lifestyle and stress factors are not significantly related.

This study found that patient-reported outcomes were similar between neoadjuvant endocrine therapy and chemotherapy in premenopausal breast cancer patients, but future perspective was significantly better with endocrine therapy.